RecruitingPhase 4NCT03384563
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
Sponsor
Baylor College of Medicine
Enrollment
180 participants
Start Date
Feb 18, 2018
Study Type
INTERVENTIONAL
Conditions
Summary
The purpose of this protocol is to determine the effect of two clinically applicable Dexmedetomidine dosages (0.5mcg/kg and 1mcg/kg) on the minimum alveolar concentration (MAC) of Sevoflurane in children between the age ranges of: 1-6 months; 6-12 months of age and 12 months-36 months years of age.
Eligibility
Min Age: 1 MonthMax Age: 36 Months
Inclusion Criteria1
- All patients age 1 month- 3 years presenting for surgery.
Exclusion Criteria14
- Interstitial lung disease, chest wall disease, or bronchospastic disease with no flare-ups in the past 2 weeks of presentation
- History of difficult intubation or ventilation
- Airway malformation
- Congenital heart disease
- Cardiac arrhythmias
- Central nervous system disease, including developmental delay, cerebral palsy, or seizure disorder
- History of or family history of malignant hyperthermia
- Electrolyte disorders
- Gastrointestinal disease
- Hepatic dysfunction
- Renal dysfunction
- Metabolic disease, such as diabetes
- Obesity, defined as a body mass index greater than the 95% percentile for age
- Preterm infant (less than 37 weeks gestational age) 15. Use of any medications (anticonvulsants, opioids, benzodiazepines, antibiotics, antihistamines drugs that induce hepatic enzymes) that may affect MAC.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGDexmedetomidine
Dexmedetomidine 9 arms
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03384563
Related Trials
Inflammatory Biomarkers and Postoperative Delirium in Pediatric Circumcision
NCT073234851 location
Pediatric Anesthesia: The Childs Voice
NCT072891524 locations
Preoperative Prediction of Difficult Airway in Children
NCT073846111 location
A New Landmark-formula for Cephalic Vein in Children
NCT073338461 location
Inflammatory Biomarkers as Predictors of PONV Following Pediatric Orchiopexy
NCT071480631 location